Synthesis of optically active monoacid side-chains of Cephalotaxus alkaloids

European Journal of Organic Chemistry

Volumn , Issue 3, 2009, Pages 437-443

  Berhal, Farouk ^a   Tardy, Sébastien ^a   Pérard Viret, Joëlle ^a   Royer, Jacques ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Alkaloids; Chirality; Epoxides; Esters; Ring opening

Indexed keywords

EID: 58649112174     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.200800935     Document Type: Article

References (39)

1. a) H. Itokawa, X. Wang, K.-H. Lee, in Anticancer Agents from Natural Products (Eds.: G. H. Cragg, D. G. I. Kingston, D. J. Newman), CRC Press, Boca Raton, FL, 2005, pp. 47-70;
2. b) J. L. Grem, B. D. Cheson, S. A. King, B. Leyland-Jones, M. Suffness, J. Natl. Cancer Inst. 1988, 80, 1095-1103;
3. c) W. Tang, G. Eisenbrand (Eds.), "Cephalotaxus spp." in Chinese Drugs of Plant Origin, Chemistry, Pharmacology, and Use in Traditional and Modern Medecine, Springer, Berlin, 1992, pp. 281-306.
4. a) R. G. Powell, D. Weisleder, C. R. Smith Jr, W. K. Rohwedder, Tetrahedron Lett. 1970, 11, 815-818;
5. b) for a review, see: M. A. Jilal Miah, T. Hudlicky, J. W. Reed in The Alkaloids (Ed.: G. A. Cordell), Academic Press, San Diego, 1998, vol. 51, pp. 199-264.
6. For recent papers on clinical trials of homoharringtonine, see: a) H. M. Kantarjian, M. Talpaz, V. Santini, A. Murgo, B. Cheson, S. M. O'Brien, Cancer 2001, 92, 1591-1605;
7. b) S. M. O'Brien, M. Talpaz, J. Cortes, J. Shan, F. J. Giles, S. Faderl, D. Thomas, G. Garcia-Manero, S. Mallard, M. B. Rios, C. Koller, S. Kornblau, M. Andreeff, A. Murgo, M. Keating, H. M. Kantarjian, Cancer 2002, 94, 2024-2032;
8. c) B. Scappini, F. Onida, H. M. Kantarjian, L. Dong, S. Verstovsek, M. J. Keating, M. Beran, Cancer 2002, 94, 2653-2662;
9. d) E. Hitt, Lancet Oncol. 2002, 3, 259;
10. e) A. Quintas-Cardama, J. Cortes, Expert Opin. Pharmacother. 2008, 9, 1029-1037;
11. f) W. G. Zhang, F. X.Wang, Y. X. Chen, X. M. Cao, A. L. He, J. Liu, X. R. Ma, W. H. Zhao, S. H. Liu, J. L. Wang, Am. J. Hematol. 2008, 83, 185-188.
12. a) W. W. Paudler, G. I. Kerley, J. McKay, J. Org. Chem. 1963, 28, 2194-2197;
13. b) R. G. Powell, D. Weisleder, C. R. Smith Jr, I. A. Wolff, Tetrahedron Lett. 1969, 10, 4081-4084;
14. c) D. J. Abraham, R. D. Rosenstein, E. L. McGandy, Tetrahedron Lett. 1969, 10, 4085-4086;
15. d) S. K. Arora, R. B. Bates, R. A. Grady, R. G. Powell, J. Org. Chem. 1974, 39, 1269-1271;
16. e) S. K. Arora, R. B. Bates, R. A. Grady, G. Germain, J. P. Declercq, R. G. Powell, J. Org. Chem. 1976, 41, 551-554.
17. a) S. Brandange, S. Josephson, S. Vallen, Acta Chem. Scand. 1974, 28, 153-156;
18. b) S. Brandange, S. Josephson, S. Vallen, Acta Chem. Scand. 1973, 27, 3668-3672;
19. c) S. Brandange, I. Granelli, B. Luning, C. Moberg, E. Sjostrand, Acta Chem. Scand. 1972, 26, 2558-2560;
20. d) S. Brandange, B. Luning, Acta Chem. Scand. 1969, 23, 1151-1154;
21. e) B. Luning, H. Trankner, S. Brandange, Acta Chem. Scand. 1966, 20, 2011;
22. f) H. Kizu, E. Kaneko, T. Tomimori, Chem. Pharm. Bull. 1999, 47, 1618-1625.
23. a) T. R. Kelly, J. C. McKenna, P. A. Christenson, Tetrahedron Lett. 1973, 14, 3501-3504;
24. b) L. Keller, F. Dumas, J. d'Angelo, Eur. J. Org. Chem. 2003, 2488-2497;
25. c) J. Auerbach, T. Ipaktchi, S. M. Weinreb, Tetrahedron Lett. 1973, 14, 4561-4564;
26. d) R. A. Ancliff, A. T. Russell, A. J. Sanderson, Chem. Commun. 2006, 3243-3245.
27. S. A. A. El Bialy, H. Braun, L. F. Tietze, Eur. J. Org. Chem. 2005, 2965-2972.
28. D. D. Perrin, W. L. F. Armarego in Purification of Laboratory Chemicals, 3rd ed., Pergamon Press, Oxford, 1988, p. 123.
29. a) C. R. Johnson, R. W. Herr, D. M. Wieland, J. Org. Chem. 1973, 38, 4263-4268;
30. b) H. M. Sirat, E. J. Thomas, J. D. Wallis, J. Chem. Soc. Perkin Trans. 1 1982, 2885-2896.
31. a) H. Gilman, R. G. Jones, L. A. Woods, J. Org. Chem. 1952, 17, 1630-1634;
32. b) B. H. Lipshutz, J. A. Kozlowski, R. S. Wilhelm, J. Org. Chem. 1983, 48, 546-550;
33. c) N. R. Schmuff, B. M. Trost, J. Org. Chem. 1983, 48, 1404-1412.
34. a) M. Ohtani, T. Matsuura, F. Watanabe, M. Narisada, J. Org. Chem. 1991, 56, 4120-4123;
35. b) J. L. Charlton, K. Koh, J. Org. Chem. 1992, 57, 1514-1516.
36. a) The same cyclization procedure was recently reported by Gin and co-workers in the preparation of anhydroharringtonine: J. D. Eckelbarger, J. T. Wilmot, M. T. Epperson, C. S. Thakur, D. Shum, C. Antczak, L. Tarassishin, H. Djaballah, D. Y. Gin, Chem. Eur. J. 2008, 14, 4293-4306;
37. b) hazards in handling mercuric acetate can be found in P. Kocovský, J. Hofferberth, "Mercury(II) acetate" in Encyclopedia of Reagents for Organic Synthesis (Ed.: L. A. Paquette), Wiley, Chichester, 1995, p. 3242.
38. T. R. Kelly, R. W. McNutt Jr, M. Montury, N. P. Tosches, K. L. Mikolajczak, C. R. Smith Jr, D. Weisleder, J. Org. Chem. 1979, 44, 63-67.
39. J.-P. Robin, R. Dhal, G. Dujardin, L. Girodier, L. Mevellec, S. Poutot, Tetrahedron Lett. 1999, 40, 2931-2934.